Stay updated with breaking news from Ryan Noach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JOHANNESBURG (AP) — A two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron variant of the coronavirus , but 70% protection against hospitalization, according to a large-scale analysis in South Africa released Tuesday.
Data from 78,000 South Africans with COVID show the Pfizer vaccine is far less effective in preventing infection by the omicron variant. But there is still significant protection from severe illness.
A study in South Africa, where the Omicron variant was first found, appears to show the new strain of COVID-19 is more transmissible, but less deadly.
Data from 78,000 South Africans with COVID show the Pfizer vaccine is far less effective in preventing infection by the omicron variant. But there is still significant protection from severe illness.
A study in South Africa, where the Omicron variant was first found, appears to show the new strain of COVID-19 is more transmissible, but less deadly.